Looking for a prescription?
Find a Doctor
Find a UK-based prescribing clinician for medical cannabis.
Market Development Since 2018
- Cannabis-based products for medicinal use were rescheduled from Schedule 1 to Schedule 2 in November 2018
- The private market developed rapidly to fill the NHS access gap
- By 2026: estimated 150,000+ patients receiving private prescriptions
- 30+ specialist clinic groups operating across the UK, many offering telehealth nationally
The UK medical cannabis market has grown significantly since legalisation — with the private sector leading development and access.
Key Market Dynamics
- Annualised prescription volumes growing at 30-40% year-on-year
- Supply primarily imported from Germany, Canada, Australia, Netherlands, and Portugal
- All imports require MHRA Import Authorisation for Schedule 2 controlled drugs
- New EU-GMP certified suppliers including Cannamedical Britannia entering the market in 2026
The UK medical cannabis market is expected to continue growing as awareness increases and NHS access pathways develop.
